Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane vs Propofol for sedation in COVID-19 ARDS
NCT04359862Phase 4Terminated
- Sponsor
- INCLIVA Biomedical Research Institute
- Start
- Apr 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sevoflurane in acute respiratory distress syndrome (ARDS), coronavirus disease 2019 (COVID-19), sponsored by INCLIVA Biomedical Research Institute. Started Apr 2020; status: terminated.
02
Drugs
sevoflurane
03
Conditions
acute respiratory distress syndrome (ARDS)coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04359862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04359862.